Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplastic Cells, Circulating × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Neoplasm Metastasis 16 Ovarian Neoplasms 7 Prostatic Neoplasms 5 Advanced Breast Cancer 5 Neoplasms 4 Breast Cancer Metastatic 4 Pancreatic Neoplasms 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Lobular 2 Breast Neoplasms, Male 2 The Neoadjuvant Therapy 1 Solid Tumor 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Salivary Gland Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Locoregional Recurrence 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Carcinoma 1

Interventions

Blood Specimen Collection 21 Liquid Biopsy 4 cabazitaxel 3 Surgical Procedures, Operative 3 Reverse Transcriptase Polymerase Chain Reaction 3 Propofol 3 Flow Cytometry 3 Bevacizumab 3 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Folfox protocol 2 Docetaxel 2 Cisplatin 2 Aspirin 2 Anesthesia, General 2 ribociclib 1 pertuzumab 1 osimertinib 1 lanreotide 1 jinfukang 1 eribulin 1 Watchful Waiting 1 Vinorelbine 1 Trastuzumab 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02958852 2025-09-10

ABC-SE

Lund University Hospital

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡